EMBECTA CORP. Ttl Fee Amt
EMBECTA CORP. (EMBC) had Ttl Fee Amt of $1.19 thousand as of 2026-08-06, per its S-8 filed 2026-08-07.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-08-07
- 2026-08-06: Ttl Fee Amt $1.19K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-08-06 | $1.19K S-8 · filed 2026-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |